(Q34576648)

3 August 2017

Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors (English)

1 reference

3 August 2017

Antonio Llombart-Bosch

6

object named as

Antonio Llombart-Bosch

1 reference

3 August 2017

7

Markku Miettinen

1 reference

3 August 2017

4

Jerzy Lasota

1 reference

3 August 2017

Reetta Assämäki

1

1 reference

3 August 2017

Maarit Sarlomo-Rikala

2

1 reference

3 August 2017

José Antonio Lopez-Guerrero

3

1 reference

3 August 2017

Leif C Andersson

5

1 reference

3 August 2017

Sakari Knuutila

8

1 reference

3 August 2017

1 June 2007

1 reference

Genes, Chromosomes and Cancer

3 August 2017

1 reference

3 August 2017

46

1 reference

3 August 2017

6

1 reference

3 August 2017

564-576

1 reference

NDRG2 expression and mutation in human liver and pancreatic cancers

3 August 2017

1 reference

Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases

21 January 2018

1 reference

KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors

21 January 2018

1 reference

KIT overexpression and amplification in gastrointestinal stromal tumors (GISTs).

21 January 2018

1 reference

Gene amplifications in osteosarcoma-CGH microarray analysis

21 January 2018

1 reference

7 January 2021

Progenetix.net: an online repository for molecular cytogenetic aberration data

1 reference

7 January 2021

Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors)

1 reference

7 January 2021

Allelic loss of 14q32 in the pathogenesis of gastrointestinal and ampullary malignancies: mapping of the target region to a 17 cM interval

1 reference

7 January 2021

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

1 reference

7 January 2021

Chromosomal aberrations in malignant gastrointestinal stromal tumors: correlation with c-KIT gene mutation.

1 reference

7 January 2021

Molecular cytogenetic definition of three distinct chromosome arm 14q deletion intervals in gastrointestinal stromal tumors

1 reference

7 January 2021

N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation

1 reference

7 January 2021

High-resolution deletion mapping of chromosome 14 in stromal tumors of the gastrointestinal tract suggests two distinct tumor suppressor loci

1 reference

7 January 2021

ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1).

1 reference

7 January 2021

Biological and clinical significance of cytogenetic abnormalities in low-risk and high-risk gastrointestinal stromal tumors

1 reference

7 January 2021

Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors.

1 reference

7 January 2021

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

1 reference

7 January 2021

PDGFRA activating mutations in gastrointestinal stromal tumors.

1 reference

7 January 2021

Pathology of gastrointestinal stromal tumors

1 reference

7 January 2021

A human poly(ADP-ribose) polymerase gene family (ADPRTL): cDNA cloning of two novel poly(ADP-ribose) polymerase homologues

1 reference

7 January 2021

Breakpoint identification and smoothing of array comparative genomic hybridization data

1 reference

7 January 2021

A cell cycle regulator potentially involved in genesis of many tumor types

1 reference

7 January 2021

Comparative genomic hybridization study on pooled DNAs from tumors of one clinical-pathological entity

1 reference

7 January 2021

Functional evidence of decreased tumorigenicity associated with monochromosome transfer of chromosome 14 in esophageal cancer and the mapping of tumor-suppressive regions to 14q32.

1 reference

7 January 2021

GISTs with PDGFRA exon 14 mutations represent subset of clinically favorable gastric tumors with epithelioid morphology

1 reference

7 January 2021

Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma

1 reference

7 January 2021

Genomic microarrays in the spotlight

1 reference

7 January 2021

Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas

1 reference

7 January 2021

Identification of new genes ndr2 and ndr3 which are related to Ndr1/RTP/Drg1 but show distinct tissue specificity and response to N-myc.

1 reference

7 January 2021

Predicting Metastatic Risk of Gastrointestinal Stromal Tumors: Role of Cell Proliferation and Cell Cycle Regulatory Proteins

1 reference

7 January 2021

9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.

1 reference

7 January 2021

Genome-wide analysis of DNA copy-number changes using cDNA microarrays

1 reference

7 January 2021

CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein

1 reference

7 January 2021

Role of p16/INK4a in gastrointestinal stromal tumor progression

1 reference

7 January 2021

Isolation of cDNA clones encoding a human apurini/apyrimidinic endonuclease that corects DNA repair and mutagenisis defects inE.coli xth(exonuclease III) mutants

1 reference

7 January 2021

Loss of heterozygosity of chromosome 9p and loss of p16INK4A expression are associated with malignant gastrointestinal stromal tumors.

1 reference

7 January 2021

Different patterns of DNA copy number changes in gastrointestinal stromal tumors, leiomyomas, and schwannomas

1 reference

7 January 2021

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

7 January 2021

Array CGH analysis in primary gastrointestinal stromal tumors: Cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.20439

1 reference

3 August 2017

1 reference